Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker

Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker Molecular Therapy 24, 1312 (July 2016). doi:10.1038/mt.2016.88 Authors: Joerg U Schmohl, Martin Felices, Elizabeth Taras, Jeff S Miller & Daniel A Vallera

http://feeds.nature.com/~r/mt/rss/current/~3/Nt5cpfk2uQc/mt.2016.88

Source: Molecular Therapy - August 9, 2016 Category: Genetics & Stem Cells Authors: Joerg U Schmohl Martin Felices Elizabeth Taras Jeff S Miller Daniel A Vallera Source Type: research

More News: Genetics